Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 57 | $4,328,599 |
Sells | 0 | $0 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Sep 2024 06:05 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 12 Aug 2024 | Purchase | 800 | 13.85 | 11,080 | D |
08 Aug 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 06 Aug 2024 | Purchase | 2,000 | 13.81 | 27,620 | D |
07 Aug 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 05 Aug 2024 | Purchase | 5,500 | 13.18 | 72,490 | D |
05 Aug 2024 06:05 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 02 Aug 2024 | Purchase | 1,000 | 15.15 | 15,150 | D |
24 Jul 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 23 Jul 2024 | Purchase | 1,500 | 15.89 | 23,835 | D |
22 Jul 2024 06:05 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 18 Jul 2024 | Purchase | 1,000 | 16 | 16,000 | D |
17 Jun 2024 06:10 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 13 Jun 2024 | Purchase | 174,825 | 14.3 | 2,499,998 | D |
03 Apr 2024 06:10 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 01 Apr 2024 | Purchase | 3,000 | 19.08 | 57,240 | D |
26 Mar 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 22 Mar 2024 | Purchase | 2,500 | 19.98 | 49,950 | D |
22 Mar 2024 06:02 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 20 Mar 2024 | Purchase | 1,500 | 17.68 | 26,520 | D |
07 Mar 2024 09:41 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 05 Mar 2024 | Purchase A | 3,500 | 12.49 | 43,715 | D |
07 Mar 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 05 Mar 2024 | Purchase | 30,500 | 12.49 | 380,945 | D |
06 Mar 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 04 Mar 2024 | Purchase | 4,100 | 13.03 | 53,423 | D |
21 Feb 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 16 Feb 2024 | Purchase | 10,800 | 11.16 | 120,528 | D |
20 Feb 2024 06:04 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 15 Feb 2024 | Purchase | 12,700 | 11.07 | 140,589 | D |
14 Nov 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 10 Nov 2023 | Purchase | 5,000 | 10.1675 | 50,838 | D |
07 Nov 2023 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 03 Nov 2023 | Purchase | 3,500 | 9.11 | 31,885 | D |
31 Oct 2023 06:16 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 27 Oct 2023 | Purchase | 500 | 8.57 | 4,285 | D |
30 Oct 2023 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 26 Oct 2023 | Purchase | 2,500 | 7.97 | 19,925 | D |
27 Oct 2023 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 25 Oct 2023 | Purchase | 2,500 | 7.91 | 19,775 | D |
12 Oct 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 10 Oct 2023 | Purchase | 1,000 | 9.07 | 9,070 | D |
05 Oct 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 04 Oct 2023 | Purchase | 2,000 | 8.63 | 17,260 | D |
28 Sep 2023 06:05 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 26 Sep 2023 | Purchase | 600 | 8.71 | 5,226 | D |
21 Sep 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 19 Sep 2023 | Purchase | 4,000 | 8.95 | 35,800 | D |
13 Sep 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 11 Sep 2023 | Purchase | 1,000 | 9.48 | 9,480 | D |
24 Aug 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 22 Aug 2023 | Purchase | 1,000 | 9.97 | 9,970 | D |
08 Aug 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 04 Aug 2023 | Purchase | 2,000 | 10.55 | 21,100 | D |
25 Jul 2023 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 21 Jul 2023 | Purchase | 1,000 | 9.2 | 9,200 | D |
17 Jul 2023 06:15 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 13 Jul 2023 | Purchase | 250 | 9.49 | 2,372 | D |
18 May 2023 06:01 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 17 May 2023 | Purchase | 1,000 | 11.69 | 11,690 | D |
02 May 2023 06:06 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 28 Apr 2023 | Purchase | 250 | 11.22 | 2,805 | D |
21 Apr 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 19 Apr 2023 | Purchase | 7,000 | 11.1 | 77,700 | D |
20 Apr 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 18 Apr 2023 | Purchase | 2,000 | 11.12 | 22,240 | D |
12 Apr 2023 06:05 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 11 Apr 2023 | Purchase | 1,000 | 11.87 | 11,870 | D |
12 Apr 2023 06:02 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 11 Apr 2023 | Purchase | 5,000 | 12.42 | 62,100 | D |
16 Mar 2023 06:05 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 15 Mar 2023 | Purchase | 250 | 12.71 | 3,178 | D |
13 Mar 2023 07:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 10 Mar 2023 | Purchase | 1,000 | 12.12 | 12,120 | D |
28 Feb 2023 06:03 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 24 Feb 2023 | Purchase | 250 | 15.395 | 3,849 | D |
22 Feb 2023 06:07 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 17 Feb 2023 | Purchase | 600 | 16.53 | 9,918 | D |
14 Feb 2023 06:08 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 10 Feb 2023 | Purchase | 1,000 | 18.68 | 18,680 | D |
07 Feb 2023 06:10 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 03 Feb 2023 | Purchase | 250 | 20.84 | 5,210 | D |
31 Jan 2023 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 27 Jan 2023 | Purchase | 2,000 | 19.35 | 38,700 | D |
30 Jan 2023 06:15 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 27 Jan 2023 | Purchase | 250 | 19.2 | 4,800 | D |
24 Jan 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 20 Jan 2023 | Purchase | 1,500 | 17.37 | 26,055 | D |
17 Jan 2023 06:02 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 13 Jan 2023 | Purchase | 250 | 16.5 | 4,125 | D |
10 Jan 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 06 Jan 2023 | Purchase | 1,500 | 15.18 | 22,770 | D |
03 Jan 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 29 Dec 2022 | Purchase | 4,000 | 15.19 | 60,760 | D |
20 Dec 2022 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 16 Dec 2022 | Purchase | 1,000 | 13.01 | 13,010 | D |
20 Dec 2022 06:05 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 16 Dec 2022 | Purchase | 250 | 12.94 | 3,235 | D |
13 Dec 2022 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 09 Dec 2022 | Purchase | 2,000 | 13.11 | 26,220 | D |
06 Dec 2022 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 02 Dec 2022 | Purchase | 1,000 | 13.84 | 13,840 | D |
06 Dec 2022 06:15 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 02 Dec 2022 | Purchase | 250 | 13.98 | 3,495 | D |
04 Nov 2022 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 02 Nov 2022 | Purchase | 2,000 | 8.79 | 17,580 | D |
17 Oct 2022 07:00 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 14 Oct 2022 | Purchase | 3,000 | 9.75 | 29,250 | D |
11 Oct 2022 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 07 Oct 2022 | Purchase | 2,000 | 9.72 | 19,440 | D |
04 Oct 2022 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 30 Sep 2022 | Purchase | 1,000 | 9.46 | 9,460 | D |
03 Oct 2022 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 29 Sep 2022 | Purchase | 1,000 | 9.23 | 9,230 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)